AFP and hepatocellular carcinoma: In the white HCC patient group, age 45‐54 years (vs age 18‐44 years; OR, 2.14; 95% CI, 1.79‐2.55; P < .01), age 55‐64 years (vs age 18‐44 years; OR, 2.01; 95% CI, 1.47‐2.23; P < .01), age 65‐–74 years (vs age 18‐44 years; OR, 1.51; 95% CI, 1.27‐1.79; P < .01), age > 75 years (vs age 18‐45 years; OR, 1.43; 95% CI, 1.21‐1.71; P < .01) were significantly associated with elevated AFP level.